Integrated BioPharma (OTCMKTS:INBP) Stock Passes Below 50 Day Moving Average – Should You Sell?

Integrated BioPharma Inc. (OTCMKTS:INBP) shares passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.18 and traded as low as $0.1602. Integrated BioPharma shares last traded at $0.1602, with a volume of 4,000 shares trading hands.

Integrated BioPharma Stock Performance

The business’s 50 day simple moving average is $0.18 and its 200-day simple moving average is $0.25. The company has a market cap of $4.96 million, a price-to-earnings ratio of -2.29 and a beta of 0.35.

Integrated BioPharma (OTCMKTS:INBP) last posted its quarterly earnings results on Friday, May 8th. The company reported ($0.03) earnings per share for the quarter. Integrated BioPharma had a negative return on equity of 8.32% and a negative net margin of 3.43%.The company had revenue of $10.11 million during the quarter.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.